research use only

Axitinib (AG-013736) Tyrosine Kinase Inhibitor

Cat.No.: S1005

Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM in Porcine aorta endothelial cells, respectively.
Jump to

Quality Control

Batch: Purity: 99.96%
99.96

Solubility in DMSO or water

In vitro
Batch:

DMSO : 26 mg/mL (67.27 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about Axitinib (AG-013736) solubility in DMSO or water

Working concentrations for cell culture treatment

Search by Cell Line | Choose a Research Area to Find Working Concentrations

Read more about Axitinib (AG-013736) working concentrations for cell culture treatment

×

Selectivity & Specificity

Axitinib (AG-013736) is a potent inhibitor of VEGFR2 (0.2 ng/ml), KDR/VEGFR2 (~260 nM), Tie2 (1.5nM), VEGF receptor 1 (0.1 nM), VEGF receptor 2 (0.2 nM), VEGF receptor 3 (0.1–0.3 nM), Human liver microsomes (10.63 μM), Rat liver microsomes (15.76 μM), VEGFR-2 kinase (19 nM), cKIT wild type (4.78 nM), cKIT V654A mutant (4.56 nM), cKIT N822K mutant (9.12 nM), cKIT T670I mutant (51.8 nM), cKIT A829P mutant (67.3 nM), cKIT D816H mutant (68.6 nM), cKIT D816V mutant (1050 nM), VEGF, VEGF-A, VEGFR, MDSCs, STAT3. Axitinib (AG-013736) exhibits the greatest inhibitory potency toward VEGF receptor 1 (IC50 = 0.1 nM).

Selectivity & Specificity Details

Mechanism of Action

Information Axitinib (AG-013736) is a potent, broad-spectrum VEGFR, PDGFR, and cKIT tyrosine kinase inhibitor. It blocks VEGF/VEGFR and cKIT signaling by inhibiting receptor autophosphorylation, effectively suppressing tumor angiogenesis, cell proliferation, and migration.

Read more about Axitinib (AG-013736) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about Axitinib (AG-013736) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 386.47 Formula

C22H18N4OS

Storage (From the date of receipt)
CAS No. 319460-85-0 Download SDF Storage of Stock Solutions

Synonyms AG 013736 Smiles CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about Axitinib (AG-013736)

Frequently Asked Questions

Question 1:
We would like to store it at -80℃ after this compound is dissolved in CMC. Do you have any information about the suggested concentration in CMC?

Answer:
In 0.5% CMC at up to 30mg/ml, it is a suspension for oral gavage administration only. We don't suggest customer to freeze down the solution but to make fresh if possible. Customer can store it for 1-2 weeks at 4 degree for continuous use.